Key statistics
On Thursday, Bio-Techne Corp (TECH:NSQ) closed at 80.36, -6.09% below its 52-week high of 85.57, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 78.32 |
---|---|
High | 80.95 |
Low | 77.58 |
Bid | 79.01 |
Offer | 81.59 |
Previous close | 76.51 |
Average volume | 879.62k |
---|---|
Shares outstanding | 158.65m |
Free float | 157.02m |
P/E (TTM) | 73.11 |
Market cap | 12.14bn USD |
EPS (TTM) | 1.05 USD |
Annual div (ADY) | 0.32 USD |
---|---|
Annual div yield (ADY) | 0.42% |
Div ex-date | Aug 19 2024 |
Div pay-date | Aug 30 2024 |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
- BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
- ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
- Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
- ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
- ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine
- BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
More ▼